Accelerated Marfan syndrome model recapitulates established signaling pathways

Area of Science:

• Cardiovascular Research
• Genetics
• Molecular Biology

Background:

• Marfan syndrome (MFS) is a genetic disorder characterized by aortic aneurysms, primarily linked to fibrillin-1 mutations and transforming growth factor beta (TGF-β) dysregulation.
• TGF-β signaling pathways are crucial in MFS pathogenesis, influencing the development of aortic aneurysms and dilated cardiomyopathies.

Purpose of the Study:

• To investigate the mechanistic relevance of a previously developed murine model of Marfan syndrome (MFS) to known signaling pathways.
• To characterize the accelerated formation of ascending aortic aneurysms and dilated cardiomyopathies in this MFS mouse model.

Main Methods:

• A fibrillin-1 deficient murine model (MFS) was supplemented with angiotensin II to accelerate aneurysm formation.
• Four groups of mice were analyzed: wild-type (WT) with or without angiotensin II, and MFS with or without angiotensin II.
• Western blotting and phosphoimaging were used to analyze signaling pathways in aortic tissue.

Main Results:

• MFS mice exhibited downstream signaling regulation in canonical (Smad2) and non-canonical (ERK, p38) pathways.
• Angiotensin II supplementation in MFS mice exaggerated these downstream signals, correlating with increased phenotypic severity.
• The accelerated MFS model demonstrated amplified activation of key MFS-related signaling cascades.

Conclusions:

• The accelerated murine MFS model effectively replicates ascending aortic aneurysm and cardiomyopathy development through established MFS signaling pathways.
• This model provides a valuable tool for expedited experimental designs aimed at further characterizing Marfan syndrome signaling.
• The findings underscore the role of TGF-β related pathways in MFS pathogenesis and the utility of this model for future research.